nathalie Lassau
机构: Professor at Gustave Roussy University Paris Saclay
每年引用次数
引用次数
引用: 18,573
H-指数: 59
I10-指数 : 151
出版物: 454
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur
Celine Bourgier , Anne Auperin , Sofia Rivera , Pierre Boisselier
International Journal of Radiation Oncology Biology Physics 104 ( 2) 365 -373
9
2019
Imagerie fonctionnelle de la réponse au traitement des cancers
Nathalie Lassau
Journal De Radiologie 88 ( 10) 1454
2007
Imaging biomarker in phase I trials: DCE-US and early evaluation of antiangiogenic treatments.
Romain Cohen , Serge Koscielny , Jean-Charles Soria , Jean-Pierre Armand
Journal of Clinical Oncology 31
2013
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.
Hédia Chagraoui , Micheline Tulliez , Tarek Smayra , Emiko Komura
Blood 101 ( 8) 2983 -2989
74
2003
Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management.
Jean Courcier , Alexandre de la Taille , Maya Nourieh , Ingrid Leguerney
International Journal of Molecular Sciences 21 ( 19) 7146
17
2020
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma
Judith Michels , Nathalie Lassau , Marine Gross-Goupil , Christophe Massard
Investigational New Drugs 28 ( 5) 690 -693
32
2010
Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour.
Julien Domont , Christophe Massard , Nathalie Lassau , Jean-Pierre Armand
Investigational New Drugs 28 ( 2) 199 -202
37
2010
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments
Ingrid Leguerney , Nathalie Lassau , Serge Koscielny , Mélanie Rodrigues
Investigational New Drugs 30 ( 1) 144 -156
9
2012
Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib
Nathalie Lassau , Linda Chami , Serge Koscielny , Mohamed Chebil
Investigational New Drugs 30 ( 2) 765 -771
73
2012
Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples
Vladimir Lazar , Nathalie Lassau , Guillaume Meurice , Yohann Loriot
Investigational New Drugs 32 ( 2) 312 -322
5
2014
Can we trust the calculation of texture indices of CT images? A phantom study
Caroline Caramella , Adrien Allorant , Fanny Orlhac , Francois Bidault
Medical Physics 45 ( 4) 1529 -1536
22
2018
Validation of imaging biomarker in a multicentric study to predict PFS in mRCC treated with TKI.
Nathalie Lassau , Serge Koscielny , Sophie Taieb , Joelle Lacroix
Journal of Clinical Oncology 32 526 -526
2014
Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre.
Margarida Matias , Gwénaël Le Teuff , Laurence Albiges , Annalisa Guida
European Journal of Cancer 79 185 -192
17
2017
Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell Carcinoma
Ingrid Leguerney , Ludovic de Rochefort , Marie Poirier-Quinot , Alexandre Ingels
Contrast Media & Molecular Imaging 2017 7498538 -7498538
1
2017
Erratum to “To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound” [European Journal of Cancer, 42 (2006) 2472–2479]
Michele Lamuraglia , Bernard Escudier , Linda Chami , Brian Schwartz
European Journal of Cancer 43 ( 8) 1336
2
2007
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound
Michele Lamuraglia , Bernard Escudier , Linda Chami , Brian Schwartz
European Journal of Cancer 42 ( 15) 2472 -2479
140
2006
Efficacy of axitinib in renal cell carcinoma: Real-world experience at Gustave Roussy (IGR).
Margarida Matias , Laurence Albiges , Nathalie Lassau , Baya Benatsou
Journal of Clinical Oncology 32
2
2014
Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results
Nathalie Lassau , Serge Koscielny , Linda Chami , Mohamed Chebil
Radiology 258 ( 1) 291 -300
179
2011
2089861 Numerical Modeling of the Dynamic Of Ultrasound Contrast Agents In Vascular Network
Laure Boyer , Stephen Randall Thomas , Ingrid Leguerney , Nathalie Lassau
Ultrasound in Medicine and Biology 41 ( 4)
1
2015
Molecular Ultrasound Imaging Using Contrast Agents Targeting Endoglin, Vascular Endothelial Growth Factor Receptor 2 and Integrin
Ingrid Leguerney , Jean-Yves Scoazec , Nicolas Gadot , Nina Robin
Ultrasound in Medicine & Biology 41 ( 1) 197 -207
22
2015